The Caffeine Conundrum: Navigating Coffee Consumption and Heart Health on September 12, 2026 Posted by
Congressional Showdown: House Veterans’ Affairs Committee Subpoenas Oracle Executives Over $27B EHR Debacle on September 12, 2026 Posted by
The "Mitch" Breakthrough: A New Frontier in Metabolic Science and Weight Management on September 12, 2026 Posted by
The Iron Stage: The 2026 USA Powerlifting Olympia Championships Return to Las Vegas on September 12, 2026 Posted by
The Brain’s Secret Ally: Yale Researchers Uncover the Surprising Role of ‘Hunger Neurons’ in GLP-1 Weight Loss on September 12, 2026 Posted by
Beyond Survival: The Philosophy of Biological Sovereignty in an Uncertain Age on September 12, 2026 Posted by
The Caffeine Conundrum: Navigating Coffee Consumption and Heart Health on September 12, 2026 Posted by
Congressional Showdown: House Veterans’ Affairs Committee Subpoenas Oracle Executives Over $27B EHR Debacle on September 12, 2026 Posted by
The "Mitch" Breakthrough: A New Frontier in Metabolic Science and Weight Management on September 12, 2026 Posted by
The Iron Stage: The 2026 USA Powerlifting Olympia Championships Return to Las Vegas on September 12, 2026 Posted by
Posted in Sleep Health Beyond the Prescription: Bridging the Gap Between Clinical Care and Lived Experience in Narcolepsy on September 11, 2026
Posted in Sleep Health A New Dawn in Sleep Medicine: The Global Rollout of Oreporexton Marks a Paradigm Shift in Narcolepsy Type 1 Care on September 9, 2026
Posted in Sleep Health FDA Accepts New Drug Application for AXS-12: A Potential Breakthrough for Narcolepsy-Associated Cataplexy on September 7, 2026
Posted in Sleep Health A New Era in Narcolepsy Care: Evaluating the Impact and Value of Oveporexton on September 6, 2026
Posted in Sleep Health A New Frontier in Sleep Medicine: Promising Phase 2 Results for Alixorexton in Narcolepsy Type 1 on September 4, 2026
Posted in Sleep Health Beyond the Prescription: Bridging the Gap Between Clinical Care and Lived Experience in Narcolepsy on September 4, 2026
Posted in Sleep Health Decoding Narcolepsy: New Research Differentiates Diagnostic Reliability in NT1 and NT2 on September 3, 2026
Posted in Sleep Health A Paradigm Shift in Sleep Medicine: FDA Approves Orzeyful (oveporexton) for Narcolepsy Type 1 on August 31, 2026
Posted in Sleep Health Unlocking the Brain’s "Sleep Brake": A Breakthrough in Understanding Narcolepsy on August 31, 2026
Posted in Sleep Health FDA Greenlights Axsome Therapeutics’ Application for Narcolepsy Treatment AXS-12 on August 30, 2026
